Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Transit times generally land at one to two business days for Ontario, Quebec, and Greater Toronto deliveries, and two to four business days for Prairie, Maritime, and northern routes
Hims & Hers raised its full-year 2026 revenue guidance to a range of $2.8 billion to $3 billion, representing growth of 19% to 28% from 2025 levels, and updated adjusted EBITDA guidance to a range of $275 million to $350 million.
Australia GLP-1 Receptor Agonist Market Companies AstraZeneca PLC Biocon Eli Lilly and Co Novo Nordisk A/S ADR Sanofi SA Latest Industry Leaders' Announcements On 21 May 2024, a complete ban on compounded tirzepatide and other compounded diabetes and weight loss medications was announced by the Australian government due to rising safety concerns and increased reports of patients experiencing side effects of these compounded drugs
BPC-157 10mg Peptide de recherche BPC-157 (Body Protection Compound 157) est un pentadcapeptide de 15 acides amins driv dune protine isole du suc gastrique humain
Our latest batch testing data shows an observed purity of 99.45% with an aligned molecular weight of 1419.5 Da
US$ 26.96
US$ 21.16
US$ 24.76
